Profit before tax jumped 64% to Rs. 226 crore, while the company maintained robust investment in innovation with net R&D spend of Rs. 249 crore
With US$ 30.46 billion in exports and robust manufacturing capabilities, the industry is poised to expand into high-value drugs while strengthening ESG and compliance standards
Four FDA-approved products strengthen portfolio and reaffirm commitment to global reach
Lasa Supergenerics Limited has been granted patent for an invention “Processes for Preparation and Purification of 5-Chloro-2-Nitroaniline
A significant proportion of healthcare professionals still tend to favor branded drugs
Dr. Reddy's aims to roll out its trade generics across cities and towns in India
Spiro will be responsible for the overall strategy, implementation and growth of Lupin’s U.S. Generics business
He has over two decades of rich experience in management consulting, advising and transforming leading generic pharmaceutical companies in India and global markets
Post this currently only Risperidone orally disintegrating tablets are allowed for import into the US from the Roorkee facility.
ICICI Direct expects revenue CAGR of 35.6% over FY22-FY24E mainly due to the consolidation of Viatris business and they expect EBITDA margin expansion of 230bps and earnings CAGR of 64.8% over FY22-FY24E
Subscribe To Our Newsletter & Stay Updated
